News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
687,032 Results
Type
Article (39107)
Company Profile (282)
Press Release (647643)
Section
Business (203886)
Career Advice (1993)
Deals (35367)
Drug Delivery (87)
Drug Development (80832)
Employer Resources (168)
FDA (16096)
Job Trends (14806)
News (344602)
Policy (32445)
Tag
Academia (2530)
Alliances (49136)
Alzheimer's disease (1248)
Approvals (16031)
Artificial intelligence (143)
Bankruptcy (352)
Best Places to Work (11561)
Biotechnology (201)
Breast cancer (161)
Cancer (1276)
Cardiovascular disease (106)
Career advice (1661)
Cell therapy (266)
Clinical research (64537)
Collaboration (439)
Compensation (244)
COVID-19 (2537)
C-suite (106)
Data (1336)
Diabetes (161)
Diagnostics (6164)
Earnings (84863)
Employer resources (146)
Events (109881)
Executive appointments (351)
FDA (16712)
Funding (397)
Gene therapy (191)
GLP-1 (590)
Government (4329)
Healthcare (18683)
Infectious disease (2624)
Inflammatory bowel disease (109)
Interviews (308)
IPO (16320)
Job creations (3625)
Job search strategy (1417)
Layoffs (415)
Legal (7857)
Lung cancer (184)
Manufacturing (194)
Medical device (13204)
Medtech (13209)
Mergers & acquisitions (19165)
Metabolic disorders (427)
Neuroscience (1557)
NextGen Class of 2024 (6500)
Non-profit (4466)
Northern California (1620)
Obesity (248)
Opinion (180)
Patents (113)
People (56369)
Phase I (20062)
Phase II (28423)
Phase III (21192)
Pipeline (496)
Postmarket research (2559)
Preclinical (8532)
Radiopharmaceuticals (236)
Rare diseases (245)
Real estate (5890)
Regulatory (21611)
Research institute (2309)
Resumes & cover letters (349)
Southern California (1409)
Startups (3562)
United States (14523)
Vaccines (558)
Weight loss (175)
Date
Today (138)
Last 7 days (636)
Last 30 days (2910)
Last 365 days (35426)
2024 (34137)
2023 (40076)
2022 (51173)
2021 (55712)
2020 (54087)
2019 (46541)
2018 (35019)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (193)
Asia (37210)
Australia (6073)
California (3630)
Canada (1383)
China (285)
Colorado (164)
Connecticut (166)
Europe (79692)
Florida (503)
Georgia (127)
Illinois (364)
Indiana (214)
Kansas (96)
Maryland (610)
Massachusetts (2831)
Michigan (165)
Minnesota (282)
New Jersey (1047)
New York (1036)
North Carolina (726)
Northern California (1620)
Ohio (144)
Pennsylvania (889)
South America (1091)
Southern California (1409)
Texas (518)
Utah (103)
Washington State (382)
687,032 Results for "lensgen inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
LensGen® Receives IDE Approval from the U.S. FDA to Begin Clinical Study of the Juvene® Presbyopia-Correcting Intraocular Lens
LensGen, Inc. announced today that it has received approval for an Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration (FDA) to initiate a pivotal study of the company’s Juvene intraocular lens (IOL) for patients with cataracts.
November 29, 2021
·
3 min read
Press Releases
ABS Bio, Inc. announces strategic investment by 3 Boomerang Capital
◆Investment to support services growth. ◆Industry veterans join board of directors, including John Chickosky as Executive Chairman, and Greg Swanberg and Martin LeBlanc as Directors.
November 14, 2024
·
1 min read
Press Releases
Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc.
November 26, 2024
·
9 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Press Releases
Senseonics Holdings, Inc. Provides Update on Eversense 365 Launch
December 10, 2024
·
10 min read
Press Releases
WW International, Inc. Announces CFO Transition
November 27, 2024
·
4 min read
Press Releases
Co-Diagnostics, Inc. and CoSara Diagnostics to Inaugurate New Oligo Facility
December 11, 2024
·
4 min read
Press Releases
Immunic, Inc. to Participate in Investor Conference in December
November 26, 2024
·
5 min read
Press Releases
OmniScience Inc. and INmune Bio Inc. Partner to Accelerate a Phase 2 Alzheimer’s Trial with Vivo, a Novel genAI Clinical Trial Control Tower
December 4, 2024
·
7 min read
Press Releases
Advantage Therapeutics Inc. Announces Formation of Klothea Bio, Inc. to Advance Research and Development of Klotho Protein for Age-Related Therapeutics
November 25, 2024
·
5 min read
1 of 68,704
Next
